Back    Zoom +    Zoom -
<Research> M Stanley: China Molybdenum (03993.HK) 1Q26 Results In Line
Recommend
10
Positive
8
Negative
3
Morgan Stanley issued a report stating that China Molybdenum (03993.HK)'s results for 1Q26 were in line with expectations, with net profit reaching RMB7.8 billion, compared with RMB3.9 billion in 1Q25 and RMB6.1 billion in 4Q25, meeting the brokers forecasts.

The broker noted that China Molybdenum delivered strong performance in 1Q26, mainly driven by increased contributions from tungsten and molybdenum at high price levels. In addition, despite a decline in copper sales volume, the gold business remained stable.

Related News Citi Adjusts Commodity Preference Ranking, Tops Copper; New Top Picks Include CATL (03750.HK), MMG (01208.HK), CMOC (03993.HK), CHALCO (02600.HK), GANFENGLITHIUM (01772.HK)
M Stanley maintained an "Overweight" rating on China Molybdenum with a TP of HKD26.3. (ha/w)
Auto-translated by AI
This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. More Details

AASTOCKS Financial News